Cyclosporine A in Ullrich Congenital Muscular Dystrophy: Long-Term Results

Six individuals with Ullrich congenital muscular dystrophy (UCMD) and mutations in the genes-encoding collagen VI, aging 5–9, received 3–5 mg/kg of cyclosporine A (CsA) daily for 1 to 3.2 years. The primary outcome measure was the muscle strength evaluated with a myometer and expressed as megalimbs....

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Merlini, Luciano, Sabatelli, Patrizia, Armaroli, Annarita, Gnudi, Saverio, Angelin, Alessia, Grumati, Paolo, Michelini, Maria Elena, Franchella, Andrea, Gualandi, Francesca, Bertini, Enrico, Maraldi, Nadir Mario, Ferlini, Alessandra, Bonaldo, Paolo, Bernardi, Paolo
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2011
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199070/
https://ncbi.nlm.nih.gov/pubmed/22028947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/139194
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы